Sweden’s unusually low smoking prevalence has long attracted international attention. Much of the discussion has focused on the country’s long history of snus use, particularly among men. But Sweden’s nicotine market is changing. Tobacco-free nicotine pouches have grown rapidly, and their uptake among women raises a new question: could a product category with broader appeal…
The evidence surrounding oral nicotine pouches has expanded rapidly. Questions that only a few years ago were being considered using a relatively small body of research can now be examined across studies covering product characteristics, nicotine delivery, toxicant exposure, patterns of use, smoking behaviour, marketing and consumer perceptions. For regulators, this expanding evidence base creates…
Nicotine markets can change faster than the systems designed to monitor them. New products enter the market, public-health controversies emerge, regulations change and consumers encounter new information online, sometimes long before conventional surveys can provide a clear picture of what is happening. This creates a challenge for regulators trying to develop policies based on current…
Nicotine pouches are increasingly caught between two competing public-health narratives. One presents them as smoke-free alternatives that could reduce harm among adults who would otherwise continue smoking. The other focuses on their potential to introduce nicotine to young people and people who have never used nicotine. A new pharmacy-focused review accepted by the Journal of…
Questions about the oral health effects of nicotine pouches have become increasingly important as their use expands. The evidence remains limited, particularly when it comes to longer-term outcomes, but a newly published Swedish clinical study adds useful data to the discussion. Published in Clinical Oral Investigations on 22 August 2026, researchers from the University of…
Youth nicotine policy often begins with a straightforward objective: prevent young people from starting to use nicotine. The harder question is how. Smoking, vaping and nicotine pouch use are sometimes grouped together in prevention strategies because they all involve nicotine. Yet young people may encounter these products in different settings, perceive them differently and respond…
A new JAMA communication on vaping raises a wider question: how should clinicians, policymakers and public-health professionals talk about nicotine pouches with adults who smoke? How health professionals communicate about nicotine matters. For years, public discussion of nicotine has often struggled to distinguish the harms caused by smoking from the effects of nicotine itself, or…
A newly accepted study in BMC Chemistry adds useful evidence to one of the central questions in nicotine regulation: how does the chemical profile of oral nicotine pouches compare with established tobacco products? The study, led by Simone Hadley and colleagues, measured 132 analytes across 11 commercially available oral nicotine pouches, alongside two Swedish snus…
For decades, nicotine regulation has been built upon laboratory science, toxicological assessments, and clinical research. These forms of evidence remain indispensable for understanding product chemistry, biological mechanisms, and potential health effects. Yet as smoke-free nicotine products continue to evolve, regulators are increasingly recognising that scientific evidence alone does not always explain how products perform in…
Why Evidence Matters in Public Health Communication A recent article published by Stanford Medicine, “Nicotine Pouches: The Tobacco Industry’s Latest Ploy?”, raises legitimate concerns about nicotine addiction and youth uptake. These are important issues that deserve serious attention and are shared concerns across the public health community. However, effective public health communication should present the…